Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Bruijning-Verhagen, Pvan Dongen, J A P
Verberk, J D M
Pijnacker, R
van Gaalen, R D
Klinkenberg, D
de Melker, H E
Mangen, M-J J
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.Published in
BMC Med 2018; 16(1):168Publiekssamenvatting
Since 2013, a biennial rotavirus pattern has emerged in the Netherlands with alternating high and low endemic years and a nearly 50% reduction in rotavirus hospitalization rates overall, while infant rotavirus vaccination has remained below 1% throughout. As the rotavirus vaccination cost-effectiveness and risk-benefit ratio in high-income settings is highly influenced by the total rotavirus disease burden, we re-evaluated two infant vaccination strategies, taking into account this recent change in rotavirus epidemiology.PMID
30196794ae974a485f413a2113503eed53cd6c53
10.1186/s12916-018-1134-3
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Archived with thanks to BMC medicine
Related articles
- Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.
- Authors: Bruijning-Verhagen P, Mangen MJ, Felderhof M, Hartwig NG, van Houten M, Winkel L, de Waal WJ, Bonten MJ
- Issue date: 2013 Apr 26
- [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
- Authors: Vitale F, Barbieri M, Dirodi B, Vitali Rosati G, Franco E
- Issue date: 2013 Jan-Feb
- Cost-effectiveness of childhood rotavirus vaccination in Germany.
- Authors: Aidelsburger P, Grabein K, Böhm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O
- Issue date: 2014 Apr 7
- Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
- Authors: Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R, Mealing N, Newall AT
- Issue date: 2017 Jan 5
- Cost-effectiveness analysis of rotavirus vaccination in Argentina.
- Authors: Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C
- Issue date: 2015 May 7